2014年 · 第49卷第09期

Postpartum hemorrhage is the leading cause of maternal death in China. The vast majority of maternal deaths caused by postpartum hemorrhage can be avoided or avoided by creating conditions. The key lies in early diagnosis and correct management^[1]。 The Obstetrics Group of Obstetrics and Gynecology Branch of Chinese Medical Association formulated and published the Guidelines for Prevention and Management of Postpartum Bleeding (Draft) in 2009^[2]It has played an important role in guiding the clinical diagnosis and treatment of postpartum hemorrhage and reducing the maternal mortality rate caused by it. In recent years, research on prevention and treatment of postpartum hemorrhage has made a lot of new progress, so it is necessary to revise the draft guidelines. The Obstetrics Group of the Obstetrics and Gynecology Branch of Chinese Medical Association organized experts to hold many discussions, and on the basis of extensive consultation, launched the Guidelines for the Prevention and Treatment of Postpartum Bleeding (2014). This guideline is revised on the basis of the Guidelines for the Prevention and Management of Postpartum Hemorrhage (Draft), mainly referring to the guidelines of WHO, International Union of Obstetricians and Gynecologists (FIGO), Canada, the United States and the United Kingdom on the diagnosis and treatment of postpartum hemorrhage, as well as the latest evidence-based medical evidence, and combining with relevant clinical experience at home and abroad, aiming to standardize and guide the prevention and management of postpartum hemorrhage by obstetricians and gynecologists across the country.

pelvic organ prolapse (POP) is an abnormal organ position and function caused by the decline of pelvic organs caused by weak pelvic floor muscles and fascia tissues. The main symptom is prolapse of vaginal opening tissue, which can be accompanied by urination, defecation and sexual dysfunction, which affects the quality of life of patients to varying degrees. POP is a common disease in middle-aged and elderly women. In recent years, the emergence of new theories and technologies has made a breakthrough in the diagnosis and treatment of POP. In order to further standardize and guide clinical practice, the Gynecological Pelvic Floor Group of Obstetrics and Gynecology Branch of Chinese Medical Association, based on the research results of evidence-based medicine at home and abroad and international treatment suggestions, combined with the specific situation in China, puts forward the following draft diagnosis and treatment guidelines for colleagues' reference.

4th Edition WHO Classification of Female Reproductive Organ Tumors^[1](New Classification for short) came out in 2014 with a brand-new look, attracting the attention of pathology and obstetrics and gynecology. And the third edition of WHO classification of female reproductive organ tumors in 2003^[2](referred to as the old classification for short) The difference is that the new classification no longer merges female reproductive organ tumors and breast tumors together, but forms separate books. The editor-in-chief of the new classification is Kurman and other four famous obstetrics and gynecology pathologists, and more than 90 experts from all over the world participated in the compilation, involving pathology, obstetrics and gynecology, oncology, epidemiology and molecular genetics. Thankfully, three of them are from mainland China. The new edition of the classification refers to 2,177 articles, basically covering the research progress of gynecological tumor etiology, pathology, epidemiology and molecular genetics in the past 10 years, fully reflecting the purpose of WHO classification, that is, as a guideline for clinical treatment; Provide a framework to organize diseases and help scientific research in depth; Can be used as a textbook for training^[2]。 The new classification will also have an impact on the pathological diagnosis of gynecological tumors in China, which will lead to corresponding changes in the clinical treatment plan and prognosis judgment of gynecological tumors. Therefore, obstetricians and gynecologists, especially gynecological oncologists, should know these important changes. This article will compare the new edition and the old edition of the classification, introduce and interpret the main changes of the new edition of the classification.